Yiming Chen

Dr. Yiming Chen

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications


1 October 2023 in International Journal of General Medicine
Verified
Journal Article
Open access
PDF file
YHYuedi Hu
Yuedi Hu
JLJian Liu
Jian Liu
LXLing Xin
Ling Xin
LWLei Wan
Lei Wan
YQYajun Qi
Yajun Qi
YCYiming Chen
Yiming Chen
Purpose: The therapeutic effects of Huangqin Qingre Chubi (HQC) in rheumatoid arthritis (RA) have been documented. However, there is a lack of real-world clinical evidence supporting its efficacy. Methods: Patients diagnosed with RA were recruited from the First Affiliated Hospital of the Anhui University of Chinese Medicine. Patient information was obtained from the hospital’s database. Propensity score matching (PSM), Kaplan–Meier curve, and Cox proportional hazards model were used to control confounding factors and analyze the factors influencing readmission. Association rule analysis and random walk evaluation models were used to evaluate the correlations among HQC treatment, inflammation indicators, and self-perception of patients (SPP) scale. Results: After PSM, 3423 patients were enrolled, with 1142 in the HQC group and 2281 in the non-HQC group. The readmission risk of the HQC group was significantly lower than that of the non-HQC group. Combined univariate and multivariate analysis results revealed that risk factors for readmission were age > 60 years, female sex, hypertension, chronic gastritis, and elevated levels of laboratory indices, including anticyclic citrullinated peptide and complement component 3 (C3) and C4. HQC, disease-modifying antirheumatic drugs, nonsteroidal anti-inflammatory drugs, and glucocorticoid therapy were protective factors for readmission. HQC treatment was closely associated with improvements in many factors, including erythrocyte sedimentation rate, C-reactive protein, C3, rheumatoid factor levels, visual analog scale, depression self-assessment scale, and patient-reported activity index scores with RA. Conclusion: HQC treatment can reduce the risk of readmission and significantly improve immune inflammatory indicators and SPP in patients with RA, with no risk of hepatorenal toxicity.

1 October 2024 in Journal of Inflammation Research
Verified
Journal Article
Open access
PDF file
SLShengfeng Liu
Shengfeng Liu
JLJian Liu
Jian Liu
XCXueni Cheng
Xueni Cheng
DFDahai Fang
Dahai Fang
XCXiaolu Chen
Xiaolu Chen
YCYiming Chen
Yiming Chen
Rheumatoid arthritis (RA) is a chronically progressive autoimmune disease with increasing age-standardized prevalence and incidence of RA worldwide. Its pathological features are persistent synovitis of the joint, accompanied by the release of a large number of inflammatory cytokines and cartilage and bone destruction. RA can lead to progressive joint damage, stiffness and swelling, vascular and bone-related complications, and irreversible disability, which seriously affects patients’ life treatment. Early diagnosis and treatment can enhance the quality of life of RA patients. Platelet-to-lymphocyte ratio (PLR), as a common indicator in routine blood tests, has been proposed as an indicator of systemic inflammation in recent years. Its clinical detection is less invasive, economical, rapid and simple, and has been applied to the clinical evaluation of a variety of diseases. Of note, this indicator is important in assessing disease activity in RA, co-diagnosing RA, detecting subclinical complications, and monitoring responses to anti-inflammatory therapy. Therefore, this review summarizes the relationship between PLR and RA and the relevant mechanisms, further advancing the understanding of the clinical value of PLR.

19 September 2025 in Medicine
Verified
Journal Article
Open access
YLYang Li
Yang Li
JLJian Liu
Jian Liu
YHYuedi Hu
Yuedi Hu
CCCheng-zhi Cong
Cheng-zhi Cong
YCYiming Chen
Yiming Chen
FWfanfan Wang
fanfan Wang
The aim of this study was to elucidate the research direction and application value of neutrophil-to-lymphocyte ratio (NLR) as an emerging inflammatory marker in rheumatoid arthritis (RA) from both literature and clinical perspectives. Firstly, we made an extensive analysis in terms of the number of publications, highly cited literature, co-cited references, and keywords. Subsequently, a retrospective exploration of clinical data of 1490 patients with rheumatic diseases admitted to the First Affiliated Hospital of Anhui University of Chinese Medicine was conducted. Logistic regression models were used to explore the independent predictive role of NLR in different scenarios. Nomogram was developed and the model was clinically evaluated by recipient operating characteristic (ROC) curves, calibration plots and decision curve analysis. In addition, association rule analysis and Mantel test were used to determine associations between NLR and clinical characteristics and self-perception of patients. A total of 544 articles were retrieved, focusing on the pathophysiology and clinical studies of RA-NLR, such as “disease activity,” “inflammation” and “classification.” Retrospective analysis demonstrated that NLR, erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels were significantly higher in RA patients than in non-RA patients. Logistic regression models identified gender, age, NLR, ESR and CRP as independent predictors of RA. The ROC curve determined a cutoff value of 2.258 for NLR and a maximum area under the curve of 0.736. Both association rule analysis and Mantel test showed that NLR was highly correlated with inflammatory markers such as ESR, CRP, and self-perception scale scores before and after treatment. NLR > 2.258 was a meaningful risk factor for moderate-to-severe pain and higher disease activity, which predictive reliability was further confirmed in subgroup stratification analyses. NLR, as a novel inflammatory marker, correlates with clinical characteristics and self-perception of RA patients, acting as an independent predictor of RA diagnosis and activity assessment.

1 October 2023 in Journal of Inflammation Research
Verified
Journal Article
Open access
PDF file
YCYiming Chen
Yiming Chen
JLJian Liu
Jian Liu
YLYang Li
Yang Li
CCChengzhi Cong
Chengzhi Cong
YHYuedi Hu
Yuedi Hu
QHQi Han
Qi Han
Since the incidence of gouty arthritis (GA) exhibits yearly increases, accurate assessment and early treatment have significant values for improving disease conditions and monitoring prognosis. Neutrophil to lymphocyte ratio (NLR) is a common indicator in blood routine, which has the characteristics of easy access and low cost. In recent years, NLR has been proven to be an effective indicator for guiding the diagnosis, treatment, and prognosis of various diseases. Moreover, NLR has varying degrees of relationship with various inflammatory biomarkers, which can affect and reflect the inflammatory response in the body. This paper reviews the independent value of NLR for GA and its underlying molecular pathological mechanisms, intending to contribute to the further application of NLR.